Published in Cancer Weekly, May 10th, 2005
"We studied the effects of 2-ME2 and 16alpha-hydroxyestrone (16alpha-OHE1), two metabolites of estradiol (E-2) on DNA synthesis, cell cycle progression and cyclin D1 protein levels in estrogen receptor-positive MCF-7 cells. E-2 and 16alpha-OHE1, stimulated DNA synthesis, and 2-ME2 inhibited the stimulatory effects of these agents. E-2 and 16alpha-OHE1, stimulated the progression of cells from G1 to S phase and this effect was attenuated by 2-ME2," scientists reported in the Journal of Molecular Endocrinology.
"Western blot analysis showed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.